<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" xmlns:podcast="https://podcastindex.org/namespace/1.0">
  <channel>
    <atom:link href="https://feeds.simplecast.com/cmy0BcAW" rel="self" title="MP3 Audio" type="application/atom+xml"/>
    <atom:link href="https://simplecast.superfeedr.com" rel="hub" xmlns="http://www.w3.org/2005/Atom"/>
    <generator>https://simplecast.com</generator>
    <title>I&apos;m Pharmacy Podcast</title>
    <description>The Leslie Dan Faculty of Pharmacy at the University of Toronto is a dynamic faculty made up of pharmacy leaders and researchers in the heart of Canada’s thriving healthcare and research ecosystem. From drug discovery to deprescribing, we are exploring and pushing the limits of the profession and the science resulting in better medications, a better health system and better health.

Join host Mina Tadrous -- a pharmacist, researcher and Leslie Dan Faculty of Pharmacy Assistant Professor -- from the heart of Toronto&apos;s Discovery District as he explores the most pressing questions in health care.

From bench to bedside, tune in for the full dose.

Host: Dr. Mina Tadrous
Production, Editing, Music: Steve Southon
Music: Diego Martinez
Production: Kate Richards

Check out Season One of the I&apos;m Pharmacy Podcast, recorded and produced by Leslie Dan Faculty of Pharmacy PharmD students.
https://soundcloud.com/pharmacy-comms</description>
    <copyright>2019-2024</copyright>
    <language>en</language>
    <pubDate>Wed, 11 Mar 2026 10:00:00 +0000</pubDate>
    <lastBuildDate>Wed, 11 Mar 2026 10:00:15 +0000</lastBuildDate>
    <image>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <title>I&apos;m Pharmacy Podcast</title>
      <url>https://image.simplecastcdn.com/images/7c2b3f0c-2241-4d7b-b7dd-f9a0c6bb30d6/902c6a20-d43a-42cb-ac1f-253da4a71ac0/3000x3000/podcast-icon-season-2-01.jpg?aid=rss_feed</url>
    </image>
    <link>https://www.pharmacy.utoronto.ca/</link>
    <itunes:type>episodic</itunes:type>
    <itunes:summary>The Leslie Dan Faculty of Pharmacy at the University of Toronto is a dynamic faculty made up of pharmacy leaders and researchers in the heart of Canada’s thriving healthcare and research ecosystem. From drug discovery to deprescribing, we are exploring and pushing the limits of the profession and the science resulting in better medications, a better health system and better health.

Join host Mina Tadrous -- a pharmacist, researcher and Leslie Dan Faculty of Pharmacy Assistant Professor -- from the heart of Toronto&apos;s Discovery District as he explores the most pressing questions in health care.

From bench to bedside, tune in for the full dose.

Host: Dr. Mina Tadrous
Production, Editing, Music: Steve Southon
Music: Diego Martinez
Production: Kate Richards

Check out Season One of the I&apos;m Pharmacy Podcast, recorded and produced by Leslie Dan Faculty of Pharmacy PharmD students.
https://soundcloud.com/pharmacy-comms</itunes:summary>
    <itunes:author>Leslie Dan Faculty of Pharmacy</itunes:author>
    <itunes:explicit>false</itunes:explicit>
    <itunes:image href="https://image.simplecastcdn.com/images/7c2b3f0c-2241-4d7b-b7dd-f9a0c6bb30d6/902c6a20-d43a-42cb-ac1f-253da4a71ac0/3000x3000/podcast-icon-season-2-01.jpg?aid=rss_feed"/>
    <itunes:new-feed-url>https://feeds.simplecast.com/cmy0BcAW</itunes:new-feed-url>
    <itunes:keywords>pharma, health, healthcare, wellness, medicine, pharmaceutical science, pharmacist, pharmacy, pharmaeutical, pharmd, undergraduate, university</itunes:keywords>
    <itunes:owner>
      <itunes:name>Leslie Dan Faculty of Pharmacy</itunes:name>
      <itunes:email>pharmacy.comms@utoronto.ca</itunes:email>
    </itunes:owner>
    <itunes:category text="Education"/>
    <itunes:category text="Health &amp; Fitness">
      <itunes:category text="Medicine"/>
    </itunes:category>
    <itunes:category text="Science">
      <itunes:category text="Life Sciences"/>
    </itunes:category>
    <item>
      <guid isPermaLink="false">82da3f5f-fdc8-451c-9de4-99bb70dd84d8</guid>
      <title>S5.E5 - Misinformation &amp; Disinformation</title>
      <description><![CDATA[Misinformation spreads fast—but how do we separate fact from opinion in an increasingly noisy information landscape? In last episode of season five, we dig into misinformation and disinformation in healthcare. We chat with Assistant Professor and Pharmacist Jennifer Lake on the critical difference between misinformation and disinformation and Associate Professor Colin Furness on why expert voices must play a bigger role in public conversations—even as the definition of “expert” itself becomes contested. The discussion also looks at the University of Toronto’s Beyond Borders initiative and how political shifts, particularly in the United States, could shape the future of health research and healthcare in Canada. Tune in for a timely conversation about trust, expertise and the fight against misinformation in public health. 
]]></description>
      <pubDate>Wed, 11 Mar 2026 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Mina Tadrous, Colin Furness, Jennifer Lake, Heather Cunningham, Lori Anne Oja)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="31712328" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/ca36a7ce-5d23-4d72-bfeb-9194b1e19650/c64b8691-448c-43c5-9237-651f955192c4/episodes/audio/group/f81b4d29-191c-4f68-96ba-0d021f063492/group-item/5e35e144-546f-49ce-adf3-8ff996bc91ef/128_default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S5.E5 - Misinformation &amp; Disinformation</itunes:title>
      <itunes:author>Mina Tadrous, Colin Furness, Jennifer Lake, Heather Cunningham, Lori Anne Oja</itunes:author>
      <itunes:duration>00:33:01</itunes:duration>
      <itunes:summary>Misinformation spreads fast—but how do we separate fact from opinion in an increasingly noisy information landscape? In last episode of season five, we dig into misinformation and disinformation in healthcare. We chat with Assistant Professor and Pharmacist Jennifer Lake on the critical difference between misinformation and disinformation and Associate Professor Colin Furness on why expert voices must play a bigger role in public conversations—even as the definition of “expert” itself becomes contested. The discussion also looks at the University of Toronto’s Beyond Borders initiative and how political shifts, particularly in the United States, could shape the future of health research and healthcare in Canada. Tune in for a timely conversation about trust, expertise and the fight against misinformation in public health.</itunes:summary>
      <itunes:subtitle>Misinformation spreads fast—but how do we separate fact from opinion in an increasingly noisy information landscape? In last episode of season five, we dig into misinformation and disinformation in healthcare. We chat with Assistant Professor and Pharmacist Jennifer Lake on the critical difference between misinformation and disinformation and Associate Professor Colin Furness on why expert voices must play a bigger role in public conversations—even as the definition of “expert” itself becomes contested. The discussion also looks at the University of Toronto’s Beyond Borders initiative and how political shifts, particularly in the United States, could shape the future of health research and healthcare in Canada. Tune in for a timely conversation about trust, expertise and the fight against misinformation in public health.</itunes:subtitle>
      <itunes:keywords>us administration changes, misinformation, public communication, factual incorrectness, scientific process, expert definition, civil discourse, healthcare professionals, vaccine misinformation, evidence pipeline, disinformation, public engagement., public trust, pubmed, social media</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>5</itunes:episode>
      <itunes:season>5</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">fb6eeaa8-b1a1-42a6-903c-bbe146aa1b64</guid>
      <title>S5.E4 - A New Hope: AI in Healthcare</title>
      <description><![CDATA[Artificial intelligence is transforming healthcare and research—but how much of it is real progress, and how much is hype? In this episode of The I’m Pharmacy Podcast, host Mina Tadrous explores the practical impact of AI across clinical care, population health, and drug discovery. Featuring insights from Dr. Devin Singh (SickKids), Professpr Laura Rosella (University of Toronto), and Assistant Professor Rachel Harding (Leslie Dan Faculty of Pharmacy), this episode examines how AI is already improving workflows and research, where limitations and risks remain, and why transparency, validation, and open science are critical to building trust. 
]]></description>
      <pubDate>Wed, 14 Jan 2026 11:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Devin Singh, Rachel Harding, Laura Rosella, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="28322073" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/60d98c27-ba7f-4976-b083-5a7fbff02290/audio/2b2df29f-2e0c-4d3a-82f2-7a1b55f76e8f/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S5.E4 - A New Hope: AI in Healthcare</itunes:title>
      <itunes:author>Devin Singh, Rachel Harding, Laura Rosella, Mina Tadrous</itunes:author>
      <itunes:duration>00:29:30</itunes:duration>
      <itunes:summary>Artificial intelligence is transforming healthcare and research—but how much of it is real progress, and how much is hype? In this episode of The I’m Pharmacy Podcast, host Mina Tadrous explores the practical impact of AI across clinical care, population health, and drug discovery. Featuring insights from Dr. Devin Singh (SickKids), Professpr Laura Rosella (University of Toronto), and Assistant Professor Rachel Harding (Leslie Dan Faculty of Pharmacy), this episode examines how AI is already improving workflows and research, where limitations and risks remain, and why transparency, validation, and open science are critical to building trust.</itunes:summary>
      <itunes:subtitle>Artificial intelligence is transforming healthcare and research—but how much of it is real progress, and how much is hype? In this episode of The I’m Pharmacy Podcast, host Mina Tadrous explores the practical impact of AI across clinical care, population health, and drug discovery. Featuring insights from Dr. Devin Singh (SickKids), Professpr Laura Rosella (University of Toronto), and Assistant Professor Rachel Harding (Leslie Dan Faculty of Pharmacy), this episode examines how AI is already improving workflows and research, where limitations and risks remain, and why transparency, validation, and open science are critical to building trust.</itunes:subtitle>
      <itunes:keywords>predictive modeling, regulatory frameworks, drug discovery, machine learning, medical innovation, data transparency, open science, ai limitations., alphafold, clinical ai, protein structure, ai in healthcare, target 2035, sick kids hospital</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>4</itunes:episode>
      <itunes:season>5</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">463e9b34-0032-4da1-89ac-3732aba6fb16</guid>
      <title>S5.E3 - Relieving the Pressure LIVE</title>
      <description><![CDATA[Pharmacy is changing fast — faster than anyone expected. In this special live episode of I’m Pharmacy, recorded at the Leslie Dan Faculty of Pharmacy, host Mina Tadrous brings together a panel of pharmacists, physicians, learners, and educators to ask a big, urgent question: How do we turn scattered progress in Ontario’s healthcare system into coordinated, collaborative, patient-centred care?

You’ll hear candid stories from the front lines of both pharmacy and family medicine — from the rapid rise of minor ailment prescribing to the immense pressures reshaping primary care. Panelists share what’s working, what’s breaking, and what absolutely must change.

Download now and join the conversation. 
]]></description>
      <pubDate>Wed, 19 Nov 2025 11:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Eric Wong, Natalie Crown, Carleigh Clarke, George Hanna, Mehreen Shahid, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="38659039" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/1828bf1e-d5a6-492c-b5d7-c6abe62c695e/audio/e93431a1-e19b-488a-b6a1-d5938a156962/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S5.E3 - Relieving the Pressure LIVE</itunes:title>
      <itunes:author>Eric Wong, Natalie Crown, Carleigh Clarke, George Hanna, Mehreen Shahid, Mina Tadrous</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/7c2b3f0c-2241-4d7b-b7dd-f9a0c6bb30d6/c17936c9-e711-41d9-9710-3f90fbbd7918/3000x3000/the-bus-is-returning-from-the-crossroads-1080p-2025-08-28-18-42-53-utc-00-00-03-21-still001.jpg?aid=rss_feed"/>
      <itunes:duration>00:40:16</itunes:duration>
      <itunes:summary>Pharmacy is changing fast — faster than anyone expected. In this special live episode of I’m Pharmacy, recorded at the Leslie Dan Faculty of Pharmacy, host Mina Tadrous brings together a panel of pharmacists, physicians, learners, and educators to ask a big, urgent question: How do we turn scattered progress in Ontario’s healthcare system into coordinated, collaborative, patient-centred care?

You’ll hear candid stories from the front lines of both pharmacy and family medicine — from the rapid rise of minor ailment prescribing to the immense pressures reshaping primary care. Panelists share what’s working, what’s breaking, and what absolutely must change.

Download now and join the conversation.</itunes:summary>
      <itunes:subtitle>Pharmacy is changing fast — faster than anyone expected. In this special live episode of I’m Pharmacy, recorded at the Leslie Dan Faculty of Pharmacy, host Mina Tadrous brings together a panel of pharmacists, physicians, learners, and educators to ask a big, urgent question: How do we turn scattered progress in Ontario’s healthcare system into coordinated, collaborative, patient-centred care?

You’ll hear candid stories from the front lines of both pharmacy and family medicine — from the rapid rise of minor ailment prescribing to the immense pressures reshaping primary care. Panelists share what’s working, what’s breaking, and what absolutely must change.

Download now and join the conversation.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>3</itunes:episode>
      <itunes:season>5</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">e63398c1-a99d-4d50-9081-9628718231d6</guid>
      <title>S5.E2 - Priced Out: In conversation with Dr. Jerry Avorn</title>
      <description><![CDATA[A few years ago, a bus full of Americans crossed the border into Canada with Senator Bernie Sanders. They weren't coming for sightseeing. They came to buy insulin.

Unlike the bus of patients heading north for insulin, most Americans can't simply cross a border to escape the system. They live with it every day. How the U.S. end up with the most expensive drug pricing in the world? 

In this episode, we discuss the current state of drug pricing in the United States with pharmaceutical policy pioneer Dr. Jerry Avorn, Professor at Harvard Medical School and author of Rethinking Medication: Truth, Power and the Drugs you Take.

Learn more: http://www.rethinkmeds.info/ 
]]></description>
      <pubDate>Wed, 15 Oct 2025 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Jerry Avorn, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="31321373" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/e53420ea-698f-4403-b493-f8bd3d7b4cfe/audio/8998bd98-f8ea-48a0-b405-cc35e1bfa9d2/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S5.E2 - Priced Out: In conversation with Dr. Jerry Avorn</itunes:title>
      <itunes:author>Jerry Avorn, Mina Tadrous</itunes:author>
      <itunes:duration>00:32:35</itunes:duration>
      <itunes:summary>A few years ago, a bus full of Americans crossed the border into Canada with Senator Bernie Sanders. They weren&apos;t coming for sightseeing. They came to buy insulin.

Unlike the bus of patients heading north for insulin, most Americans can&apos;t simply cross a border to escape the system. They live with it every day. How the U.S. end up with the most expensive drug pricing in the world? 

In this episode, we discuss the current state of drug pricing in the United States with pharmaceutical policy pioneer Dr. Jerry Avorn, Professor at Harvard Medical School and author of Rethinking Medication: Truth, Power and the Drugs you Take.

Learn more: http://www.rethinkmeds.info/</itunes:summary>
      <itunes:subtitle>A few years ago, a bus full of Americans crossed the border into Canada with Senator Bernie Sanders. They weren&apos;t coming for sightseeing. They came to buy insulin.

Unlike the bus of patients heading north for insulin, most Americans can&apos;t simply cross a border to escape the system. They live with it every day. How the U.S. end up with the most expensive drug pricing in the world? 

In this episode, we discuss the current state of drug pricing in the United States with pharmaceutical policy pioneer Dr. Jerry Avorn, Professor at Harvard Medical School and author of Rethinking Medication: Truth, Power and the Drugs you Take.

Learn more: http://www.rethinkmeds.info/</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>2</itunes:episode>
      <itunes:season>5</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">f63c64f0-16f7-4ce8-a973-695e8d5c7486</guid>
      <title>S5.E1 - Defunding Discovery</title>
      <description><![CDATA[Trump’s Whitehouse is at war with national funding institutions, pausing hundreds of research projects both nationally and internationally. How are Canadian researchers coping with widespread funding cuts, and who pays the price when science is under attack?

Featuring:
•	Bradly Wouters, executive vice-president science and research, University Health Network 
•	Adam Bjorndahl, associate professor, Department of Philosophy, Carnegie Mellon University  
]]></description>
      <pubDate>Wed, 17 Sep 2025 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Bradly Wouters, Adam Bjorndahl, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="33858966" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/29983505-af41-4d6f-9d32-ce06bce32830/audio/f894eb30-65b4-4939-9cd5-49ea6c0f8d30/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S5.E1 - Defunding Discovery</itunes:title>
      <itunes:author>Bradly Wouters, Adam Bjorndahl, Mina Tadrous</itunes:author>
      <itunes:duration>00:35:16</itunes:duration>
      <itunes:summary>Trump’s Whitehouse is at war with national funding institutions, pausing hundreds of research projects both nationally and internationally. How are Canadian researchers coping with widespread funding cuts, and who pays the price when science is under attack?

Featuring:
•	Bradly Wouters, executive vice-president science and research, University Health Network 
•	Adam Bjorndahl, associate professor, Department of Philosophy, Carnegie Mellon University </itunes:summary>
      <itunes:subtitle>Trump’s Whitehouse is at war with national funding institutions, pausing hundreds of research projects both nationally and internationally. How are Canadian researchers coping with widespread funding cuts, and who pays the price when science is under attack?

Featuring:
•	Bradly Wouters, executive vice-president science and research, University Health Network 
•	Adam Bjorndahl, associate professor, Department of Philosophy, Carnegie Mellon University </itunes:subtitle>
      <itunes:keywords>national institutes of health, us federal budget cuts, canadian institute of health research, artificial intelligence, research collaboration, defunding discovery, pharmaceutical pricing, science funding, brain drain, scientific economy, global fight against misinformation, canada leads program, catalysts for change</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
      <itunes:season>5</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">06d2d06f-ad29-4cc9-b22a-2a3aba928991</guid>
      <title>Season Five Teaser: Rounds Table x I&apos;m Pharmacy: Tableside Chat with Mina Tadrous</title>
      <description><![CDATA[We're baaaaaack! Season Five launches September 17. As a sneak peek of what's to come, we sat down with Dr. Mike Fralick on the Rounds Table to chat about the upcoming season, musings on the future of AI and drug discovery, and whether Mike can hold his own in a 90's-style rap battle.

Check out episode one of our new season, launching September 17. 
]]></description>
      <pubDate>Thu, 11 Sep 2025 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Mike Fralick, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="35543342" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/d0da567e-cd7a-4a83-ab26-971d3a0e30ac/audio/6a08195b-5564-4d01-93cc-55d67f504f7c/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>Season Five Teaser: Rounds Table x I&apos;m Pharmacy: Tableside Chat with Mina Tadrous</itunes:title>
      <itunes:author>Mike Fralick, Mina Tadrous</itunes:author>
      <itunes:duration>00:37:01</itunes:duration>
      <itunes:summary>We&apos;re baaaaaack! Season Five launches September 17. As a sneak peek of what&apos;s to come, we sat down with Dr. Mike Fralick on the Rounds Table to chat about the upcoming season, musings on the future of AI and drug discovery, and whether Mike can hold his own in a 90&apos;s-style rap battle.

Check out episode one of our new season, launching September 17.</itunes:summary>
      <itunes:subtitle>We&apos;re baaaaaack! Season Five launches September 17. As a sneak peek of what&apos;s to come, we sat down with Dr. Mike Fralick on the Rounds Table to chat about the upcoming season, musings on the future of AI and drug discovery, and whether Mike can hold his own in a 90&apos;s-style rap battle.

Check out episode one of our new season, launching September 17.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>bonus</itunes:episodeType>
      <itunes:season>5</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">64354705-ef5c-4df2-b824-9439174daf42</guid>
      <title>S4.E7: Consider This - Part Two</title>
      <description><![CDATA[In the final episode of the season, we continue our discussion exploring the often overlooked consequences of innovation. In the last episode, we focused on the outcomes of new innovation on existing healthcare systems, exploring ethical access and economic influence. Today, we discuss who innovation can leave behind, and why it is essential that medical breakthroughs benefit everyone.

Featuring:
Jaris Swidrovich
Assistant Professor and Indigenous Engagement Lead, Leslie Dan Faculty of Pharmacy
Founder and Chair, Indigenous Pharmacy Professionals of Canada

Hagar Labouta,
Assistant Professor, Leslie Dan Faculty of Pharmacy
Scientist, Keenan Research Center for Biomedical Science, Unity Health Toronto
 
]]></description>
      <pubDate>Thu, 1 Aug 2024 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Leslie Dan Faculty of Pharmacy)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="25731750" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/5276c6db-554b-41af-9058-9bf3973f5c31/audio/8a08037d-70c2-4042-98e0-7e1109aa2ef9/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S4.E7: Consider This - Part Two</itunes:title>
      <itunes:author>Leslie Dan Faculty of Pharmacy</itunes:author>
      <itunes:duration>00:26:48</itunes:duration>
      <itunes:summary>In the final episode of the season, we continue our discussion exploring the often overlooked consequences of innovation. In the last episode, we focused on the outcomes of new innovation on existing healthcare systems, exploring ethical access and economic influence. Today, we discuss who innovation can leave behind, and why it is essential that medical breakthroughs benefit everyone.

Featuring:
Jaris Swidrovich
Assistant Professor and Indigenous Engagement Lead, Leslie Dan Faculty of Pharmacy
Founder and Chair, Indigenous Pharmacy Professionals of Canada

Hagar Labouta,
Assistant Professor, Leslie Dan Faculty of Pharmacy
Scientist, Keenan Research Center for Biomedical Science, Unity Health Toronto
</itunes:summary>
      <itunes:subtitle>In the final episode of the season, we continue our discussion exploring the often overlooked consequences of innovation. In the last episode, we focused on the outcomes of new innovation on existing healthcare systems, exploring ethical access and economic influence. Today, we discuss who innovation can leave behind, and why it is essential that medical breakthroughs benefit everyone.

Featuring:
Jaris Swidrovich
Assistant Professor and Indigenous Engagement Lead, Leslie Dan Faculty of Pharmacy
Founder and Chair, Indigenous Pharmacy Professionals of Canada

Hagar Labouta,
Assistant Professor, Leslie Dan Faculty of Pharmacy
Scientist, Keenan Research Center for Biomedical Science, Unity Health Toronto
</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>7</itunes:episode>
      <itunes:season>4</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">0ddb70b7-e7d1-4ab7-8b29-56dd989e29d5</guid>
      <title>S4.E6: Consider This - Part One</title>
      <description><![CDATA[Like a train moving at a fast pace, innovation can feel unstoppable. In many ways, the only path is forward.

But like all good things, we must take a pause to ensure we aren't blinded with the excitement of potential and hope. To end the season, we wanted to use the next two episodes to do just that—pause and explore what we must and should consider as we create this new future with innovations.  We'll delve into the ethics of access, probing into who truly owns innovation and whether there are alternative ways to incentivize groundbreaking advancements.

So join us as we ask ourselves—and you—to consider this.

Featured Guests:
Dr. Alison Thompson
Associate Professor, Leslie Dan Faculty of Pharmacy & Dalla Lana School of Public Health

Dr. Quinn Grundy
Assistant Professor Lawrence Bloomberg Faculty of Nursing
Director, World Health Organization Collaborating Centre for Governance, Accountability and Transparency in the Pharmaceutical Sector 
]]></description>
      <pubDate>Tue, 2 Jul 2024 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Dr. Quinn Grundy, Dr. Alison Thompson, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="30607662" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/665ae5c3-bbb4-4821-a1bb-091b49c16e2b/audio/2dc47c78-871e-43bf-bb46-7175079a19da/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S4.E6: Consider This - Part One</itunes:title>
      <itunes:author>Dr. Quinn Grundy, Dr. Alison Thompson, Mina Tadrous</itunes:author>
      <itunes:duration>00:31:52</itunes:duration>
      <itunes:summary>Like a train moving at a fast pace, innovation can feel unstoppable. In many ways, the only path is forward.

But like all good things, we must take a pause to ensure we aren&apos;t blinded with the excitement of potential and hope. To end the season, we wanted to use the next two episodes to do just that—pause and explore what we must and should consider as we create this new future with innovations.  We&apos;ll delve into the ethics of access, probing into who truly owns innovation and whether there are alternative ways to incentivize groundbreaking advancements.

So join us as we ask ourselves—and you—to consider this.

Featured Guests:
Dr. Alison Thompson
Associate Professor, Leslie Dan Faculty of Pharmacy &amp; Dalla Lana School of Public Health

Dr. Quinn Grundy
Assistant Professor Lawrence Bloomberg Faculty of Nursing
Director, World Health Organization Collaborating Centre for Governance, Accountability and Transparency in the Pharmaceutical Sector</itunes:summary>
      <itunes:subtitle>Like a train moving at a fast pace, innovation can feel unstoppable. In many ways, the only path is forward.

But like all good things, we must take a pause to ensure we aren&apos;t blinded with the excitement of potential and hope. To end the season, we wanted to use the next two episodes to do just that—pause and explore what we must and should consider as we create this new future with innovations.  We&apos;ll delve into the ethics of access, probing into who truly owns innovation and whether there are alternative ways to incentivize groundbreaking advancements.

So join us as we ask ourselves—and you—to consider this.

Featured Guests:
Dr. Alison Thompson
Associate Professor, Leslie Dan Faculty of Pharmacy &amp; Dalla Lana School of Public Health

Dr. Quinn Grundy
Assistant Professor Lawrence Bloomberg Faculty of Nursing
Director, World Health Organization Collaborating Centre for Governance, Accountability and Transparency in the Pharmaceutical Sector</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>6</itunes:episode>
      <itunes:season>4</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">d2f396af-dacc-4ddf-9af4-86425ec6efd7</guid>
      <title>S4.E5. - Spreading the Cure: Diffusion and Implementation</title>
      <description><![CDATA[The internet is full of examples of failed innovations... The Segway, The PalmPilot, MySpace... tech that started revolutions, but failed to scale. This phenomenon is not specific to Silicon Valley. In fact, it is very present in healthcare.

On this episode of the I'm Pharmacy Podcast, we chat diffusion and implementation. What can innovators learn from failed innovatrions to better navigate the healthcare market? Chatting with industry experts, we will explore in the world of developing interventions, and the emerging excitement of artificial intelligence in healthcare.

Featured guests:

Dr. Jeremy Grimshaw
Senior Scientist at The Ottawa Hospital Research Institute,
Professor in the Department of Medicine at the University of Ottawa

Dr. Muhammad Mamdani
Vice President of Data Science and Advanced Analytics at Unity Health Toronto
Director, U of T's Centre for Artificial Intelligence, Education and Research and Medicine
Professor (status), Leslie Dan Faculty of Pharmacy 
]]></description>
      <pubDate>Thu, 30 May 2024 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Leslie Dan Faculty of Pharmacy)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="33476533" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/400ecd36-42f9-4b65-b46e-dd3c3df20502/audio/658e1456-a25d-4b4e-b872-7d8eb3b8068a/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S4.E5. - Spreading the Cure: Diffusion and Implementation</itunes:title>
      <itunes:author>Leslie Dan Faculty of Pharmacy</itunes:author>
      <itunes:duration>00:34:52</itunes:duration>
      <itunes:summary>The internet is full of examples of failed innovations... The Segway, The PalmPilot, MySpace... tech that started revolutions, but failed to scale. This phenomenon is not specific to Silicon Valley. In fact, it is very present in healthcare.

On this episode of the I&apos;m Pharmacy Podcast, we chat diffusion and implementation. What can innovators learn from failed innovatrions to better navigate the healthcare market? Chatting with industry experts, we will explore in the world of developing interventions, and the emerging excitement of artificial intelligence in healthcare.

Featured guests:

Dr. Jeremy Grimshaw
Senior Scientist at The Ottawa Hospital Research Institute,
Professor in the Department of Medicine at the University of Ottawa

Dr. Muhammad Mamdani
Vice President of Data Science and Advanced Analytics at Unity Health Toronto
Director, U of T&apos;s Centre for Artificial Intelligence, Education and Research and Medicine
Professor (status), Leslie Dan Faculty of Pharmacy</itunes:summary>
      <itunes:subtitle>The internet is full of examples of failed innovations... The Segway, The PalmPilot, MySpace... tech that started revolutions, but failed to scale. This phenomenon is not specific to Silicon Valley. In fact, it is very present in healthcare.

On this episode of the I&apos;m Pharmacy Podcast, we chat diffusion and implementation. What can innovators learn from failed innovatrions to better navigate the healthcare market? Chatting with industry experts, we will explore in the world of developing interventions, and the emerging excitement of artificial intelligence in healthcare.

Featured guests:

Dr. Jeremy Grimshaw
Senior Scientist at The Ottawa Hospital Research Institute,
Professor in the Department of Medicine at the University of Ottawa

Dr. Muhammad Mamdani
Vice President of Data Science and Advanced Analytics at Unity Health Toronto
Director, U of T&apos;s Centre for Artificial Intelligence, Education and Research and Medicine
Professor (status), Leslie Dan Faculty of Pharmacy</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>5</itunes:episode>
      <itunes:season>4</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">1ecc0234-cee4-4033-aced-a08f608947c5</guid>
      <title>S4.E4. - Prototyping Progress</title>
      <description><![CDATA[So you have a good idea... no, a great idea. The science is solid. The tech is exciting. People are interested.  Your innovation and its success seems certain. And yet, you fail to make the jump from an exciting idea to scaling up and being successful.

As we explore the art of prototyping, and early launches, we'll explore how these foundational ideas are assessed for market fit. Join us as we explore the intricate dance of innovation and practicality for each prototype. Together, we'll uncover how these early models are pivotal and paving the way for innovation to really take flight.

Featuring:

Dr. Keith Pardee
Associate Professor, Leslie Dan Faculty of Pharmacy
Canada Research Chair in Synthetic Biology and Human Health

Mike Sullivan
CEO and Co-founder, Cubic Health 
]]></description>
      <pubDate>Tue, 30 Apr 2024 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Mike Sullivan, Keith Pardee, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="29407757" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/39fa115a-7288-4c9b-bbe1-3beeb1d865bf/audio/e63019b9-2ae3-4cc2-a76c-73b244aae665/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S4.E4. - Prototyping Progress</itunes:title>
      <itunes:author>Mike Sullivan, Keith Pardee, Mina Tadrous</itunes:author>
      <itunes:duration>00:30:37</itunes:duration>
      <itunes:summary>So you have a good idea... no, a great idea. The science is solid. The tech is exciting. People are interested.  Your innovation and its success seems certain. And yet, you fail to make the jump from an exciting idea to scaling up and being successful.

As we explore the art of prototyping, and early launches, we&apos;ll explore how these foundational ideas are assessed for market fit. Join us as we explore the intricate dance of innovation and practicality for each prototype. Together, we&apos;ll uncover how these early models are pivotal and paving the way for innovation to really take flight.

Featuring:

Dr. Keith Pardee
Associate Professor, Leslie Dan Faculty of Pharmacy
Canada Research Chair in Synthetic Biology and Human Health

Mike Sullivan
CEO and Co-founder, Cubic Health</itunes:summary>
      <itunes:subtitle>So you have a good idea... no, a great idea. The science is solid. The tech is exciting. People are interested.  Your innovation and its success seems certain. And yet, you fail to make the jump from an exciting idea to scaling up and being successful.

As we explore the art of prototyping, and early launches, we&apos;ll explore how these foundational ideas are assessed for market fit. Join us as we explore the intricate dance of innovation and practicality for each prototype. Together, we&apos;ll uncover how these early models are pivotal and paving the way for innovation to really take flight.

Featuring:

Dr. Keith Pardee
Associate Professor, Leslie Dan Faculty of Pharmacy
Canada Research Chair in Synthetic Biology and Human Health

Mike Sullivan
CEO and Co-founder, Cubic Health</itunes:subtitle>
      <itunes:keywords>pharmacist, pharmacy, funded, technology, innovation, market, prototyping, lab, synthetic biology</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>4</itunes:episode>
      <itunes:season>4</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">57f9b6c4-262a-493e-bc2e-353d36693676</guid>
      <title>S4.E3. - Champions of Change</title>
      <description><![CDATA[Here we go on the path of innovation. On this episode, we build on the pathway of innovation to better understand how change occurs, how the spark of a novel discovery can really kick start this journey. We do believe that all good innovation should be grounded in strong science. But how and where does it start? Where does the initial spark come from? How does the scientist see a discovery and select this path? Do they know this from the onset? Has it shaped the questions they ask? Or is it a mere process that occurs as part of good science.

Featured Guests:
Dr. Molly Shoichet
University Professor
Department of Chemical Engineering, University of Toronto

Dr. Tim Corson,
Professor
Leslie Dan Faculty of Pharmacy, University of Toronto 
]]></description>
      <pubDate>Tue, 2 Apr 2024 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Molly Shoichet, Tim Corson, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="35261450" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/b08fb610-a8e1-4b99-9475-3848e3b1289e/audio/7f2ce508-6a2d-4b8c-ae1f-cf18b39f19c6/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S4.E3. - Champions of Change</itunes:title>
      <itunes:author>Molly Shoichet, Tim Corson, Mina Tadrous</itunes:author>
      <itunes:duration>00:36:43</itunes:duration>
      <itunes:summary>Here we go on the path of innovation. On this episode, we build on the pathway of innovation to better understand how change occurs, how the spark of a novel discovery can really kick start this journey. We do believe that all good innovation should be grounded in strong science. But how and where does it start? Where does the initial spark come from? How does the scientist see a discovery and select this path? Do they know this from the onset? Has it shaped the questions they ask? Or is it a mere process that occurs as part of good science.

Featured Guests:
Dr. Molly Shoichet
University Professor
Department of Chemical Engineering, University of Toronto

Dr. Tim Corson,
Professor
Leslie Dan Faculty of Pharmacy, University of Toronto</itunes:summary>
      <itunes:subtitle>Here we go on the path of innovation. On this episode, we build on the pathway of innovation to better understand how change occurs, how the spark of a novel discovery can really kick start this journey. We do believe that all good innovation should be grounded in strong science. But how and where does it start? Where does the initial spark come from? How does the scientist see a discovery and select this path? Do they know this from the onset? Has it shaped the questions they ask? Or is it a mere process that occurs as part of good science.

Featured Guests:
Dr. Molly Shoichet
University Professor
Department of Chemical Engineering, University of Toronto

Dr. Tim Corson,
Professor
Leslie Dan Faculty of Pharmacy, University of Toronto</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>3</itunes:episode>
      <itunes:season>4</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">db5b9082-4d2d-4ed3-b975-859212b6fec4</guid>
      <title>S4.E2. - From Lab to Market</title>
      <description><![CDATA[Historically, academia has been breeding ground for groundbreaking discoveries. But often these findings remained confined within Academic Journals lacking the pathway to real world applications. However, as technology transfer offices popped up around universities around the world, entrepreneurial programs, catalysts, collaborative initiatives, universities are more and more recognizing the value of translating their research into products and therapies that can benefit society.

As communities around the world grapple with complex health challenges, there's a growing pressure to deliver innovative solutions in a timely manner. This has driven academia to actively engage in commercialization and look at it as a means to fund science students and really just keep the lights on in many labs. So, that's what we'll explore this episode. Why does commercialization take place? Why should academics even bother? And is it a driving force for innovation? We'll learn from some real efforts that have been occurring here at the University of Toronto, and those that have been involved in them.

Featured Guests

Dr. Paul Santerre
Professor & Baxter Chair in Health Technology & Commercialization at University of Toronto's Institute of Biomedical Engineering and University Health Networks
Director, Health Innovation Hub 

Dr. Christine Allen
Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
Co-founder and CEO, Intrepid Labs 
]]></description>
      <pubDate>Tue, 5 Mar 2024 11:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Christine Allen, Paul Santerre, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="32978139" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/546f1919-4517-40ff-9406-111a59781939/audio/823d3964-964c-46d3-babb-0b1adc9c4a61/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S4.E2. - From Lab to Market</itunes:title>
      <itunes:author>Christine Allen, Paul Santerre, Mina Tadrous</itunes:author>
      <itunes:duration>00:34:21</itunes:duration>
      <itunes:summary>Historically, academia has been breeding ground for groundbreaking discoveries. But often these findings remained confined within Academic Journals lacking the pathway to real world applications. However, as technology transfer offices popped up around universities around the world, entrepreneurial programs, catalysts, collaborative initiatives, universities are more and more recognizing the value of translating their research into products and therapies that can benefit society.

As communities around the world grapple with complex health challenges, there&apos;s a growing pressure to deliver innovative solutions in a timely manner. This has driven academia to actively engage in commercialization and look at it as a means to fund science students and really just keep the lights on in many labs. So, that&apos;s what we&apos;ll explore this episode. Why does commercialization take place? Why should academics even bother? And is it a driving force for innovation? We&apos;ll learn from some real efforts that have been occurring here at the University of Toronto, and those that have been involved in them.

Featured Guests

Dr. Paul Santerre
Professor &amp; Baxter Chair in Health Technology &amp; Commercialization at University of Toronto&apos;s Institute of Biomedical Engineering and University Health Networks
Director, Health Innovation Hub 

Dr. Christine Allen
Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
Co-founder and CEO, Intrepid Labs</itunes:summary>
      <itunes:subtitle>Historically, academia has been breeding ground for groundbreaking discoveries. But often these findings remained confined within Academic Journals lacking the pathway to real world applications. However, as technology transfer offices popped up around universities around the world, entrepreneurial programs, catalysts, collaborative initiatives, universities are more and more recognizing the value of translating their research into products and therapies that can benefit society.

As communities around the world grapple with complex health challenges, there&apos;s a growing pressure to deliver innovative solutions in a timely manner. This has driven academia to actively engage in commercialization and look at it as a means to fund science students and really just keep the lights on in many labs. So, that&apos;s what we&apos;ll explore this episode. Why does commercialization take place? Why should academics even bother? And is it a driving force for innovation? We&apos;ll learn from some real efforts that have been occurring here at the University of Toronto, and those that have been involved in them.

Featured Guests

Dr. Paul Santerre
Professor &amp; Baxter Chair in Health Technology &amp; Commercialization at University of Toronto&apos;s Institute of Biomedical Engineering and University Health Networks
Director, Health Innovation Hub 

Dr. Christine Allen
Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
Co-founder and CEO, Intrepid Labs</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>2</itunes:episode>
      <itunes:season>4</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">59fdee05-6aba-4dd0-be65-33123caac06c</guid>
      <title>S4. E1. - Eureka!</title>
      <description><![CDATA[Welcome to Season Four.

Join us in kicking-off a new season of the I'm Pharmacy Podcast as we explore the heart and soul of the academic endeavour, innovation.

Now, before you roll your eyes about another podcast focusing on innovation, this season goes beyond a re-telling of success, and gets to the bottom of where innovation comes from. We dive deep into where ideas come from, what failures led to success, and the difficulties of taking an innovation from idea to intervention.

In our first episode, we chat eureka moments with Dr. Quynh Pham, the Scientific Director and Principal Investigator, Centre for Digital Therapeutics, University Health Network, as well as Dr, Michael LaFlamme, Senior Scientist at the McEwen Stem Cell Institute, University Health Network. 
]]></description>
      <pubDate>Wed, 24 Jan 2024 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Leslie Dan Faculty of Pharmacy)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="38108358" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/45c720dd-cc6a-4b5a-992a-d675fd21af2e/audio/90d785cf-7d3d-4614-b4dd-9de4f9a3c5b9/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S4. E1. - Eureka!</itunes:title>
      <itunes:author>Leslie Dan Faculty of Pharmacy</itunes:author>
      <itunes:duration>00:39:41</itunes:duration>
      <itunes:summary>Welcome to Season Four.

Join us in kicking-off a new season of the I&apos;m Pharmacy Podcast as we explore the heart and soul of the academic endeavour, innovation.

Now, before you roll your eyes about another podcast focusing on innovation, this season goes beyond a re-telling of success, and gets to the bottom of where innovation comes from. We dive deep into where ideas come from, what failures led to success, and the difficulties of taking an innovation from idea to intervention.

In our first episode, we chat eureka moments with Dr. Quynh Pham, the Scientific Director and Principal Investigator, Centre for Digital Therapeutics, University Health Network, as well as Dr, Michael LaFlamme, Senior Scientist at the McEwen Stem Cell Institute, University Health Network.</itunes:summary>
      <itunes:subtitle>Welcome to Season Four.

Join us in kicking-off a new season of the I&apos;m Pharmacy Podcast as we explore the heart and soul of the academic endeavour, innovation.

Now, before you roll your eyes about another podcast focusing on innovation, this season goes beyond a re-telling of success, and gets to the bottom of where innovation comes from. We dive deep into where ideas come from, what failures led to success, and the difficulties of taking an innovation from idea to intervention.

In our first episode, we chat eureka moments with Dr. Quynh Pham, the Scientific Director and Principal Investigator, Centre for Digital Therapeutics, University Health Network, as well as Dr, Michael LaFlamme, Senior Scientist at the McEwen Stem Cell Institute, University Health Network.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
      <itunes:season>4</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">9eee244c-b73b-4f50-8cb3-ad506633bbfb</guid>
      <title>MINISERIES Ep 3: The Future of Pharmacy Is...</title>
      <description><![CDATA[In the final episode of season three, we're turning our spotlight to the ones who will be the forefront of tomorrow's pharmacy landscape, our pharmacy students.

Featuring:
Theodora Udounwa, fourth year PharmD student, Leslie Dan Faculty of Pharmacy
Al-Amin Ahamed, fourth year PharmD student, Leslie Dan Faculty of Pharmacy
Madelynn Hannah, pharmacist and MScPhm trainee, Leslie Dan Faculty of Pharmacy 
]]></description>
      <pubDate>Thu, 24 Aug 2023 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Leslie Dan Faculty of Pharmacy)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="23741785" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/e4720619-c102-4098-bb31-6f1654e1b198/audio/2278647a-35cd-40f3-8c97-b58d720fb639/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>MINISERIES Ep 3: The Future of Pharmacy Is...</itunes:title>
      <itunes:author>Leslie Dan Faculty of Pharmacy</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/7c2b3f0c-2241-4d7b-b7dd-f9a0c6bb30d6/606f878b-ab82-4df0-8026-83a0af7cfb9a/3000x3000/pharmacy-in-focus.jpg?aid=rss_feed"/>
      <itunes:duration>00:24:43</itunes:duration>
      <itunes:summary>In the final episode of season three, we&apos;re turning our spotlight to the ones who will be the forefront of tomorrow&apos;s pharmacy landscape, our pharmacy students.

Featuring:
Theodora Udounwa, fourth year PharmD student, Leslie Dan Faculty of Pharmacy
Al-Amin Ahamed, fourth year PharmD student, Leslie Dan Faculty of Pharmacy
Madelynn Hannah, pharmacist and MScPhm trainee, Leslie Dan Faculty of Pharmacy</itunes:summary>
      <itunes:subtitle>In the final episode of season three, we&apos;re turning our spotlight to the ones who will be the forefront of tomorrow&apos;s pharmacy landscape, our pharmacy students.

Featuring:
Theodora Udounwa, fourth year PharmD student, Leslie Dan Faculty of Pharmacy
Al-Amin Ahamed, fourth year PharmD student, Leslie Dan Faculty of Pharmacy
Madelynn Hannah, pharmacist and MScPhm trainee, Leslie Dan Faculty of Pharmacy</itunes:subtitle>
      <itunes:keywords>opportunity, patients, pharmacy, community, profession, discovery, scope, future, pharmacists, providing, antidepressant, pandemic, students, episode, medication, spoke, dispensing, people</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>8</itunes:episode>
      <itunes:season>3</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">c8beb24c-4b46-4d72-96ce-534abf2bb85a</guid>
      <title>&apos;MINISERIES Ep 2: Blank Slate - Live from CPERC 2023</title>
      <description><![CDATA[What is the pharmacist of the future, and how do we train them?

Recorded live at the 2023 Canadian Pharmacy Education and Research Conference in Winnipeg, Manitoba, host Mina Tadrous explores the future of pharmacy education alongside an esteemed panel of pharmacists and pharmacy educators.

Featuring:
Taylor Raiche, University of Saskatchewan
Natalie Kennie-Kaulbach, Dalhousie University 
Sandra Jarvis-Selinger, University of British Columbia
Lalitha Raman-Wilms, University of Manitoba  
]]></description>
      <pubDate>Mon, 10 Jul 2023 18:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Taylor Raiche, Natalie Kennie Kaulbach, Lalitha Raman-Wilms, Sandra Jarvis Selinger, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="46216766" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/67d1703a-f832-48b4-b02d-08673f1d9387/audio/401b8e79-2f0d-4b8c-86f4-4e446204849c/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>&apos;MINISERIES Ep 2: Blank Slate - Live from CPERC 2023</itunes:title>
      <itunes:author>Taylor Raiche, Natalie Kennie Kaulbach, Lalitha Raman-Wilms, Sandra Jarvis Selinger, Mina Tadrous</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/7c2b3f0c-2241-4d7b-b7dd-f9a0c6bb30d6/3a74d224-a8a9-4911-acf7-575595ae1ebb/3000x3000/pharmacy-in-focus.jpg?aid=rss_feed"/>
      <itunes:duration>00:48:08</itunes:duration>
      <itunes:summary>What is the pharmacist of the future, and how do we train them?

Recorded live at the 2023 Canadian Pharmacy Education and Research Conference in Winnipeg, Manitoba, host Mina Tadrous explores the future of pharmacy education alongside an esteemed panel of pharmacists and pharmacy educators.

Featuring:
Taylor Raiche, University of Saskatchewan
Natalie Kennie-Kaulbach, Dalhousie University 
Sandra Jarvis-Selinger, University of British Columbia
Lalitha Raman-Wilms, University of Manitoba </itunes:summary>
      <itunes:subtitle>What is the pharmacist of the future, and how do we train them?

Recorded live at the 2023 Canadian Pharmacy Education and Research Conference in Winnipeg, Manitoba, host Mina Tadrous explores the future of pharmacy education alongside an esteemed panel of pharmacists and pharmacy educators.

Featuring:
Taylor Raiche, University of Saskatchewan
Natalie Kennie-Kaulbach, Dalhousie University 
Sandra Jarvis-Selinger, University of British Columbia
Lalitha Raman-Wilms, University of Manitoba </itunes:subtitle>
      <itunes:keywords>opportunity, patients, pharmacy, curriculum, medications, preceptors, pharmacists, change, primary care, students, practice, diversity, program</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>7</itunes:episode>
      <itunes:season>3</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">af64b4cd-66ec-4ebb-9d5e-04c67f95fe9b</guid>
      <title>MINISERIES Ep 1: Pharmacy&apos;s Moment</title>
      <description><![CDATA[Tune in to the first episode of our I'm Pharmacy Podcast Miniseries 'Pharmacy in Focus'. Throughout the next three episodes, we'll be exploring the current state of pharmacy practice, education and research, and uncovering what the future holds for the profession of pharmacy.

In the first episode, we take a trip to Southhampton, Ontario to speak to Pharmacist and Pharmacy Owner Kristen Watt about how her pharmacy model could pave the way for a new era of pharmacy, as well as Leslie Dan Faculty of Pharmacy Associate Dean Academic Jamie Kellar on pharmacist identity. 
]]></description>
      <pubDate>Mon, 12 Jun 2023 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Leslie Dan Faculty of Pharmacy)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="36564835" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/707c48fc-d0e5-4446-bac3-42bf7c601423/audio/7b08f553-394f-4e14-982c-43f77805fd9b/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>MINISERIES Ep 1: Pharmacy&apos;s Moment</itunes:title>
      <itunes:author>Leslie Dan Faculty of Pharmacy</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/7c2b3f0c-2241-4d7b-b7dd-f9a0c6bb30d6/4fa0d0c3-e5c5-4f35-b429-8813b8ca9445/3000x3000/pharmacy-in-focus.jpg?aid=rss_feed"/>
      <itunes:duration>00:38:05</itunes:duration>
      <itunes:summary>Tune in to the first episode of our I&apos;m Pharmacy Podcast Miniseries &apos;Pharmacy in Focus&apos;. Throughout the next three episodes, we&apos;ll be exploring the current state of pharmacy practice, education and research, and uncovering what the future holds for the profession of pharmacy.

In the first episode, we take a trip to Southhampton, Ontario to speak to Pharmacist and Pharmacy Owner Kristen Watt about how her pharmacy model could pave the way for a new era of pharmacy, as well as Leslie Dan Faculty of Pharmacy Associate Dean Academic Jamie Kellar on pharmacist identity.</itunes:summary>
      <itunes:subtitle>Tune in to the first episode of our I&apos;m Pharmacy Podcast Miniseries &apos;Pharmacy in Focus&apos;. Throughout the next three episodes, we&apos;ll be exploring the current state of pharmacy practice, education and research, and uncovering what the future holds for the profession of pharmacy.

In the first episode, we take a trip to Southhampton, Ontario to speak to Pharmacist and Pharmacy Owner Kristen Watt about how her pharmacy model could pave the way for a new era of pharmacy, as well as Leslie Dan Faculty of Pharmacy Associate Dean Academic Jamie Kellar on pharmacist identity.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>6</itunes:episode>
      <itunes:season>3</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">895179c5-68a8-4547-b49a-07be2e3316af</guid>
      <title>S3.E5: Our Mental Health Crisis</title>
      <description><![CDATA[In today's episode, we tackle a crisis that affects millions of individuals worldwide, and has reached an alarming proportion in Canada. We're going to talk about the mental health crisis. Mental health disorders have long been a significant concern. In recent years, the magnitude of the problem just feels like it's escalated, leaving a profound effect on individuals, families and communities.

Featured guests:

Dr. Paul Kurdyak
Psychiatrist and Vice President Clinical for the Mental Health and Addiction Center of Excellence at Ontario Health

Dr. Simone Vigod
Head of Department of Psychiatry at Women's College Hospital 
]]></description>
      <pubDate>Mon, 29 May 2023 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Paul Kurdyak, Simone Vigod, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="37514020" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/b31addc8-3981-4f03-914f-e738b0afeb82/audio/10f24f07-3671-4f87-b8f1-13a48a267929/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S3.E5: Our Mental Health Crisis</itunes:title>
      <itunes:author>Paul Kurdyak, Simone Vigod, Mina Tadrous</itunes:author>
      <itunes:duration>00:39:04</itunes:duration>
      <itunes:summary>In today&apos;s episode, we tackle a crisis that affects millions of individuals worldwide, and has reached an alarming proportion in Canada. We&apos;re going to talk about the mental health crisis. Mental health disorders have long been a significant concern. In recent years, the magnitude of the problem just feels like it&apos;s escalated, leaving a profound effect on individuals, families and communities.

Featured guests:

Dr. Paul Kurdyak
Psychiatrist and Vice President Clinical for the Mental Health and Addiction Center of Excellence at Ontario Health

Dr. Simone Vigod
Head of Department of Psychiatry at Women&apos;s College Hospital</itunes:summary>
      <itunes:subtitle>In today&apos;s episode, we tackle a crisis that affects millions of individuals worldwide, and has reached an alarming proportion in Canada. We&apos;re going to talk about the mental health crisis. Mental health disorders have long been a significant concern. In recent years, the magnitude of the problem just feels like it&apos;s escalated, leaving a profound effect on individuals, families and communities.

Featured guests:

Dr. Paul Kurdyak
Psychiatrist and Vice President Clinical for the Mental Health and Addiction Center of Excellence at Ontario Health

Dr. Simone Vigod
Head of Department of Psychiatry at Women&apos;s College Hospital</itunes:subtitle>
      <itunes:keywords>care, issues, virtual, medications, anxiety, depression, pandemic, therapy, work, addictions, postpartum, psychiatrists, pregnancy, psychiatry, mental health</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>5</itunes:episode>
      <itunes:season>3</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">c3d6ba60-eb10-4803-8e33-07799e228249</guid>
      <title>S3.E4: Putting Evidence Into Action</title>
      <description><![CDATA[We produce lots of science. There's an estimated 125,000, medical or clinical studies published per month, in 2021. That means that there's over a million different papers with lots of different evidence in different spaces being produced a year.
And yet, with all of this knowledge, we seem to see a plateau in people's health and health outcomes. How can it be that despite the availability of high quality evidence, amazing science, and proven effective interventions, there's a delay or a failure to get this knowledge into practice?

In this episode of the I'm Pharmacy Podcast, we dig into moving evidence into action, speaking with family physician and scientist Dr. Noah Ivers and implementation scientist Dr. Tina Fahim. 
]]></description>
      <pubDate>Mon, 24 Apr 2023 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Dr. Noah Ivers, Dr. Tina Fahim, Mina Tadrous, Steve Southon)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="32657564" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/f826feda-e110-4005-80f2-d46ccf71367b/audio/5ccb2f3c-039c-4062-b1de-c9822417d8f1/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S3.E4: Putting Evidence Into Action</itunes:title>
      <itunes:author>Dr. Noah Ivers, Dr. Tina Fahim, Mina Tadrous, Steve Southon</itunes:author>
      <itunes:duration>00:34:01</itunes:duration>
      <itunes:summary>We produce lots of science. There&apos;s an estimated 125,000, medical or clinical studies published per month, in 2021. That means that there&apos;s over a million different papers with lots of different evidence in different spaces being produced a year.
And yet, with all of this knowledge, we seem to see a plateau in people&apos;s health and health outcomes. How can it be that despite the availability of high quality evidence, amazing science, and proven effective interventions, there&apos;s a delay or a failure to get this knowledge into practice?

In this episode of the I&apos;m Pharmacy Podcast, we dig into moving evidence into action, speaking with family physician and scientist Dr. Noah Ivers and implementation scientist Dr. Tina Fahim.</itunes:summary>
      <itunes:subtitle>We produce lots of science. There&apos;s an estimated 125,000, medical or clinical studies published per month, in 2021. That means that there&apos;s over a million different papers with lots of different evidence in different spaces being produced a year.
And yet, with all of this knowledge, we seem to see a plateau in people&apos;s health and health outcomes. How can it be that despite the availability of high quality evidence, amazing science, and proven effective interventions, there&apos;s a delay or a failure to get this knowledge into practice?

In this episode of the I&apos;m Pharmacy Podcast, we dig into moving evidence into action, speaking with family physician and scientist Dr. Noah Ivers and implementation scientist Dr. Tina Fahim.</itunes:subtitle>
      <itunes:keywords>prescribe, studies, question, patient, barriers, implementation, systems, habit, intervention, quality, clinical outcomes, problem, creating, practice, implement, clinicians, evidence, antibiotics, people, outcomes</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>4</itunes:episode>
      <itunes:season>3</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">0c82f7f0-714a-4ac6-a540-429ff5793555</guid>
      <title>S3.E3: Dose of Reality: Access to Medications</title>
      <description><![CDATA[Medications are an integral part of our healthcare system, and yet their access is grossly limited around the world. On this episode of the I'm Pharmacy Podcast, we dive into the issue of access to medicine, both globally and in Canada, with family physician Dr. Danielle Martin and Leslie Dan Faculty of Pharmacy Professor Jillian Kohler. 
]]></description>
      <pubDate>Tue, 28 Mar 2023 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Danielle Martin, Jillian Kohler, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="32609081" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/47b8860d-fa2a-4bd1-8dbe-c3f84834d6be/audio/98fea17e-847a-47f5-a6b6-a8e4390817b5/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S3.E3: Dose of Reality: Access to Medications</itunes:title>
      <itunes:author>Danielle Martin, Jillian Kohler, Mina Tadrous</itunes:author>
      <itunes:duration>00:33:58</itunes:duration>
      <itunes:summary>Medications are an integral part of our healthcare system, and yet their access is grossly limited around the world. On this episode of the I&apos;m Pharmacy Podcast, we dive into the issue of access to medicine, both globally and in Canada, with family physician Dr. Danielle Martin and Leslie Dan Faculty of Pharmacy Professor Jillian Kohler.</itunes:summary>
      <itunes:subtitle>Medications are an integral part of our healthcare system, and yet their access is grossly limited around the world. On this episode of the I&apos;m Pharmacy Podcast, we dive into the issue of access to medicine, both globally and in Canada, with family physician Dr. Danielle Martin and Leslie Dan Faculty of Pharmacy Professor Jillian Kohler.</itunes:subtitle>
      <itunes:keywords>universal pharmacare, drugs, health care, medications, pharmacists, who, access to medicine, medicines, pharmacare, essential medicines</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>3</itunes:episode>
      <itunes:season>3</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">1e155351-b164-4693-83a8-9a7cbd2c526b</guid>
      <title>S3.E2 - The Next Pandemic</title>
      <description><![CDATA[Where were you when you first heard the news about the pandemic?

On this episode of the I'm Pharmacy Podcast, we dig into the pandemic, what the last three years have looked like, and if we are ready for the next one. To discuss, we chat with Emily Musing, inaugural leader in residence at the Leslie Dan Faculty of Pharmacy. And former VP clinical and the chief Patient Safety Officer at the University Health Network, as well as Leslie Dan Faculty of Pharmacy Assistant Professor and mRNA expert, Bowen Li. 
]]></description>
      <pubDate>Tue, 28 Feb 2023 11:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Emily Musings, Bowen Li, Steve Southon, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="32627241" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/4c34eded-f312-4aee-b12a-df24b86a8413/audio/d4dd81c7-1a7d-483a-be8c-6d73e606e26f/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S3.E2 - The Next Pandemic</itunes:title>
      <itunes:author>Emily Musings, Bowen Li, Steve Southon, Mina Tadrous</itunes:author>
      <itunes:duration>00:33:59</itunes:duration>
      <itunes:summary>Where were you when you first heard the news about the pandemic?

On this episode of the I&apos;m Pharmacy Podcast, we dig into the pandemic, what the last three years have looked like, and if we are ready for the next one. To discuss, we chat with Emily Musing, inaugural leader in residence at the Leslie Dan Faculty of Pharmacy. And former VP clinical and the chief Patient Safety Officer at the University Health Network, as well as Leslie Dan Faculty of Pharmacy Assistant Professor and mRNA expert, Bowen Li.</itunes:summary>
      <itunes:subtitle>Where were you when you first heard the news about the pandemic?

On this episode of the I&apos;m Pharmacy Podcast, we dig into the pandemic, what the last three years have looked like, and if we are ready for the next one. To discuss, we chat with Emily Musing, inaugural leader in residence at the Leslie Dan Faculty of Pharmacy. And former VP clinical and the chief Patient Safety Officer at the University Health Network, as well as Leslie Dan Faculty of Pharmacy Assistant Professor and mRNA expert, Bowen Li.</itunes:subtitle>
      <itunes:keywords>pharmacy, drugs, technology, canada, mra, antigen, pandemic, mrna, coronavirus, covid-19, covid, clinic</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>2</itunes:episode>
      <itunes:season>3</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">09287e06-c9d3-4950-9d1c-b5cb1351601f</guid>
      <title>S3.E1 Bugs and Drugs</title>
      <description><![CDATA[In the first episode of season three, we dive into what the World Health Organization calls one of the major public health threats to humanity, antimicrobial resistance. To discuss AMR, and what scientists and health care providers are doing to battle it, we chat with pharmacotherapy specialist Mark McIntyre and Associate Professor in U of T's Department of Molecular Genetics, William Navarre. 
]]></description>
      <pubDate>Tue, 24 Jan 2023 11:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Mark McIntyre, William Navarre, Steve Southon, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="34543584" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/55bfd78f-efa4-4215-831c-8c4138249e22/audio/f54b0760-293d-4960-8739-6c010fdf0f3e/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S3.E1 Bugs and Drugs</itunes:title>
      <itunes:author>Mark McIntyre, William Navarre, Steve Southon, Mina Tadrous</itunes:author>
      <itunes:duration>00:35:58</itunes:duration>
      <itunes:summary>In the first episode of season three, we dive into what the World Health Organization calls one of the major public health threats to humanity, antimicrobial resistance. To discuss AMR, and what scientists and health care providers are doing to battle it, we chat with pharmacotherapy specialist Mark McIntyre and Associate Professor in U of T&apos;s Department of Molecular Genetics, William Navarre.</itunes:summary>
      <itunes:subtitle>In the first episode of season three, we dive into what the World Health Organization calls one of the major public health threats to humanity, antimicrobial resistance. To discuss AMR, and what scientists and health care providers are doing to battle it, we chat with pharmacotherapy specialist Mark McIntyre and Associate Professor in U of T&apos;s Department of Molecular Genetics, William Navarre.</itunes:subtitle>
      <itunes:keywords>pharmacy, university of toronto, pharmaceutical sciences, molecular genetics, antimicrobial resistance, penicillin, amr, stewardship, medication, antibiotics</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
      <itunes:season>3</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">8236ab4e-25ce-41f4-8f83-274acf7a69e0</guid>
      <title>Introducing Season Three: Big Problems, Bigger Solutions</title>
      <description><![CDATA[Introducing Season Three of the I'm Pharmacy Podcast: Big Problems, Bigger Solutions dropping January 24.

Big thanks to everyone who showed their support for the show and helped us bring home a silver and listener's choice signal award in the category of science and education!  
]]></description>
      <pubDate>Wed, 18 Jan 2023 20:30:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Steve Southon, Kate Richards, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="707638" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/17a54b30-9ede-4b83-b41e-799de9626fef/audio/5258d6d0-34e0-466f-8a44-5df142e43c1f/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>Introducing Season Three: Big Problems, Bigger Solutions</itunes:title>
      <itunes:author>Steve Southon, Kate Richards, Mina Tadrous</itunes:author>
      <itunes:duration>00:00:44</itunes:duration>
      <itunes:summary>Introducing Season Three of the I&apos;m Pharmacy Podcast: Big Problems, Bigger Solutions dropping January 24.

Big thanks to everyone who showed their support for the show and helped us bring home a silver and listener&apos;s choice signal award in the category of science and education! </itunes:summary>
      <itunes:subtitle>Introducing Season Three of the I&apos;m Pharmacy Podcast: Big Problems, Bigger Solutions dropping January 24.

Big thanks to everyone who showed their support for the show and helped us bring home a silver and listener&apos;s choice signal award in the category of science and education! </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>trailer</itunes:episodeType>
      <itunes:season>3</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">8b6d0615-8fe7-4583-9d33-39b5ea5faa53</guid>
      <title>S2.E8: Show me the Money!</title>
      <description><![CDATA[The global pharmaceutical market is expected to grow to $1.6 trillion this year. In Canada alone, we spend close to $35 billion a year on prescription drugs. This is big money, and Big Pharma.

On the last episode of season two, we explore the world of drug pricing and access, chatting with Vice President and Head of Medical, Global Influenza and COVID Franchises Dr. Ayman Chit, and GreenShield Canada Vice-President Pharmacy Benefits Management, Dr. Ned Pojskic.

Thanks for listening, and we'll see you soon for season three! 
]]></description>
      <pubDate>Wed, 27 Jul 2022 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Ayman Chit, Ned Pojskic, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="37231480" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/5063edf0-a812-427e-a2e3-8f3a1d17dc6a/audio/2f220cec-b77c-4854-bd1c-efc13bb4a5c1/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S2.E8: Show me the Money!</itunes:title>
      <itunes:author>Ayman Chit, Ned Pojskic, Mina Tadrous</itunes:author>
      <itunes:duration>00:38:46</itunes:duration>
      <itunes:summary>The global pharmaceutical market is expected to grow to $1.6 trillion this year. In Canada alone, we spend close to $35 billion a year on prescription drugs. This is big money, and Big Pharma.

On the last episode of season two, we explore the world of drug pricing and access, chatting with Vice President and Head of Medical, Global Influenza and COVID Franchises Dr. Ayman Chit, and GreenShield Canada Vice-President Pharmacy Benefits Management, Dr. Ned Pojskic.

Thanks for listening, and we&apos;ll see you soon for season three!</itunes:summary>
      <itunes:subtitle>The global pharmaceutical market is expected to grow to $1.6 trillion this year. In Canada alone, we spend close to $35 billion a year on prescription drugs. This is big money, and Big Pharma.

On the last episode of season two, we explore the world of drug pricing and access, chatting with Vice President and Head of Medical, Global Influenza and COVID Franchises Dr. Ayman Chit, and GreenShield Canada Vice-President Pharmacy Benefits Management, Dr. Ned Pojskic.

Thanks for listening, and we&apos;ll see you soon for season three!</itunes:subtitle>
      <itunes:keywords>pharmacist, medication cost, pharmacy, health system, drug pricing, drug, pharmaceutical, innovation, healthcare, drug insurance, medication, prices, private payer</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>8</itunes:episode>
      <itunes:season>2</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">fe848ed7-b3d3-46aa-b079-0b1f9f257c8c</guid>
      <title>S2.E7: Optimized Use</title>
      <description><![CDATA[Recent estimates suggest that close to 40% of adults over the age of 65 are prescribed at least five drugs. But is more better?

On this episode on the I'm Pharmacy Podcast we tackle the topic of optimized use, discussing the process of deprescribing, prescribing cascades, and polypharmacy with Clinician Scientist Lisa McCarthy and Leslie Dan Faculty of Pharmacy Professor and Dean Lisa Dolovich. 
]]></description>
      <pubDate>Tue, 7 Jun 2022 19:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Leslie Dan Faculty of Pharmacy)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="38200727" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/56bb66ac-0f2c-4215-be20-77f54448aeaf/audio/72f34f95-cf05-4a26-9820-87004ed3efe0/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S2.E7: Optimized Use</itunes:title>
      <itunes:author>Leslie Dan Faculty of Pharmacy</itunes:author>
      <itunes:duration>00:39:47</itunes:duration>
      <itunes:summary>Recent estimates suggest that close to 40% of adults over the age of 65 are prescribed at least five drugs. But is more better?

On this episode on the I&apos;m Pharmacy Podcast we tackle the topic of optimized use, discussing the process of deprescribing, prescribing cascades, and polypharmacy with Clinician Scientist Lisa McCarthy and Leslie Dan Faculty of Pharmacy Professor and Dean Lisa Dolovich.</itunes:summary>
      <itunes:subtitle>Recent estimates suggest that close to 40% of adults over the age of 65 are prescribed at least five drugs. But is more better?

On this episode on the I&apos;m Pharmacy Podcast we tackle the topic of optimized use, discussing the process of deprescribing, prescribing cascades, and polypharmacy with Clinician Scientist Lisa McCarthy and Leslie Dan Faculty of Pharmacy Professor and Dean Lisa Dolovich.</itunes:subtitle>
      <itunes:keywords>pharmacist, pharmacy, prescription, polypharmacy, medicine, medication management, deprescribing, prescribing cascades</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>7</itunes:episode>
      <itunes:season>2</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">40834ca5-2f5f-4b83-9450-29d95c45be7d</guid>
      <title>S2.E6: Drug Safety</title>
      <description><![CDATA[How do we study the safety of drugs? Who studies them? And what does that mean to our risk tolerance of medications? Host Mina Tadrous explores these questions with Pharmacoepidemiologist Dr. Tara Gomes and Clinical Pharmacologist Dr. David Juurlink.  
]]></description>
      <pubDate>Fri, 29 Apr 2022 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (David Juurlink, Tara Gomes, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="41197015" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/00237c70-a16d-4e1c-8d99-54ab87401d9e/audio/8f477459-9aa3-4ec9-83bd-188e5d5e114a/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S2.E6: Drug Safety</itunes:title>
      <itunes:author>David Juurlink, Tara Gomes, Mina Tadrous</itunes:author>
      <itunes:duration>00:42:54</itunes:duration>
      <itunes:summary>How do we study the safety of drugs? Who studies them? And what does that mean to our risk tolerance of medications? Host Mina Tadrous explores these questions with Pharmacoepidemiologist Dr. Tara Gomes and Clinical Pharmacologist Dr. David Juurlink. </itunes:summary>
      <itunes:subtitle>How do we study the safety of drugs? Who studies them? And what does that mean to our risk tolerance of medications? Host Mina Tadrous explores these questions with Pharmacoepidemiologist Dr. Tara Gomes and Clinical Pharmacologist Dr. David Juurlink. </itunes:subtitle>
      <itunes:keywords>pharmacy, drugs, observational studies, drug policy, medication, clinical trials, drug safety</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>6</itunes:episode>
      <itunes:season>2</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">105323a4-1459-4807-a438-f0cf94439eea</guid>
      <title>S2.E5: On Trial</title>
      <description><![CDATA[Today, and as we've seen throughout this pandemic, clinical trials are the commonplace for how any new treatment gets approved. It is the gatekeeper to anything getting stocked on the shelves of pharmacies or hospitals. And that's what I want to dive into in this episode. How are trials planned? What does it take to complete one? What are all the different components that go into this gold standard for clinical evidence, the final step before market access.

To help answer these questions, we chat with Dr. Rob Van Exan, a veteran of the industry with over 35 years of experience in vaccine development, and Dr.  Lee Dupuis, a Clinician Scientist at the Leslie Dan Faculty of Pharmacy and the Hospital for Sick Children. 
]]></description>
      <pubDate>Wed, 30 Mar 2022 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Mina Tadrous, Lee Dupuis, Rob Van Exan)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="39724188" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/d99ddc70-33d8-419f-891d-6480b6e2f30c/audio/32feaff7-9c87-4fd4-8ae7-c12c7d0a6d43/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S2.E5: On Trial</itunes:title>
      <itunes:author>Mina Tadrous, Lee Dupuis, Rob Van Exan</itunes:author>
      <itunes:duration>00:41:23</itunes:duration>
      <itunes:summary>Today, and as we&apos;ve seen throughout this pandemic, clinical trials are the commonplace for how any new treatment gets approved. It is the gatekeeper to anything getting stocked on the shelves of pharmacies or hospitals. And that&apos;s what I want to dive into in this episode. How are trials planned? What does it take to complete one? What are all the different components that go into this gold standard for clinical evidence, the final step before market access.

To help answer these questions, we chat with Dr. Rob Van Exan, a veteran of the industry with over 35 years of experience in vaccine development, and Dr.  Lee Dupuis, a Clinician Scientist at the Leslie Dan Faculty of Pharmacy and the Hospital for Sick Children.</itunes:summary>
      <itunes:subtitle>Today, and as we&apos;ve seen throughout this pandemic, clinical trials are the commonplace for how any new treatment gets approved. It is the gatekeeper to anything getting stocked on the shelves of pharmacies or hospitals. And that&apos;s what I want to dive into in this episode. How are trials planned? What does it take to complete one? What are all the different components that go into this gold standard for clinical evidence, the final step before market access.

To help answer these questions, we chat with Dr. Rob Van Exan, a veteran of the industry with over 35 years of experience in vaccine development, and Dr.  Lee Dupuis, a Clinician Scientist at the Leslie Dan Faculty of Pharmacy and the Hospital for Sick Children.</itunes:subtitle>
      <itunes:keywords>placebo, vaccine, regulators, vaccines, pediatrics, clinical trials, drug safety</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>5</itunes:episode>
      <itunes:season>2</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">b1de8e18-d8c2-4de7-951b-75bbdf239b71</guid>
      <title>S2.E4: Perfect Form</title>
      <description><![CDATA[How do we pick how to introduce the right molecule into the body in the right way? Well, there's a lot of things to consider. How was it absorbed into the body? Where and how is it broken down? What's the size of the molecule? What is it treating? And where do we want it to go? There's lots of different questions to determine the right formulation. So today we explore the magic of formulations. Why is it important? How do we decide from a laundry list of different medications formulations  And how do we develop new formulations that haven't yet been developed? 
]]></description>
      <pubDate>Mon, 28 Feb 2022 17:30:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Mina Tadrous, Kan Kaneko, Ping Lee)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="27955767" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/00a70b56-27be-469f-88c0-1669d64b32e2/audio/8a569499-2cd0-4cb7-acc8-646ac92d933b/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S2.E4: Perfect Form</itunes:title>
      <itunes:author>Mina Tadrous, Kan Kaneko, Ping Lee</itunes:author>
      <itunes:duration>00:29:07</itunes:duration>
      <itunes:summary>How do we pick how to introduce the right molecule into the body in the right way? Well, there&apos;s a lot of things to consider. How was it absorbed into the body? Where and how is it broken down? What&apos;s the size of the molecule? What is it treating? And where do we want it to go? There&apos;s lots of different questions to determine the right formulation. So today we explore the magic of formulations. Why is it important? How do we decide from a laundry list of different medications formulations  And how do we develop new formulations that haven&apos;t yet been developed?</itunes:summary>
      <itunes:subtitle>How do we pick how to introduce the right molecule into the body in the right way? Well, there&apos;s a lot of things to consider. How was it absorbed into the body? Where and how is it broken down? What&apos;s the size of the molecule? What is it treating? And where do we want it to go? There&apos;s lots of different questions to determine the right formulation. So today we explore the magic of formulations. Why is it important? How do we decide from a laundry list of different medications formulations  And how do we develop new formulations that haven&apos;t yet been developed?</itunes:subtitle>
      <itunes:keywords>patents, pharmacist, formulation, delivery, pharmacy, compounding, pharmaceutical scientists, capsules, drug, research, compund, drug research, antigens, drug formulation, vaccines, amorphous, medication, lab, life sciences</itunes:keywords>
      <itunes:explicit>true</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>4</itunes:episode>
      <itunes:season>2</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">9d93a9d6-35d5-4b85-ae9c-6839e1d040a0</guid>
      <title>S2.E3: The Big Leap</title>
      <description><![CDATA[The process of moving from a potential drug molecule to being on the shelf of a pharmacy is a long and winding journey. On average, from the time the molecule is discovered to when it's actually approved by the FDA, it takes 12 to 15 years. More importantly, it costs close to $1 billion to bring a drug to market. It's also estimated that of the 1000s of molecules that are looked at, only a few will make it to clinical development, and following that, only five to six percent will survive and ended up being submitted for regulatory review.

So how do we choose the winning horse? On this episode of the I'm Pharmacy Podcast we talk to Leslie Dan Faculty of Pharmacy researchers Professor Micheline Piquette Miller, Professor Raymond Reilly, and Dr. Jennifer Doucet on just what it takes to conduct translational research, and the excitement of seeing one's research leave the lab. 
]]></description>
      <pubDate>Thu, 27 Jan 2022 11:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Micheline Piquette Miller, Raymond Reilly, Jennifer Doucet, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="40001713" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/c285fe46-4f63-41fe-9282-7c771552f64b/audio/6ae1b3f7-aa6b-4ff1-8bb6-13e95925637e/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S2.E3: The Big Leap</itunes:title>
      <itunes:author>Micheline Piquette Miller, Raymond Reilly, Jennifer Doucet, Mina Tadrous</itunes:author>
      <itunes:duration>00:41:40</itunes:duration>
      <itunes:summary>The process of moving from a potential drug molecule to being on the shelf of a pharmacy is a long and winding journey. On average, from the time the molecule is discovered to when it&apos;s actually approved by the FDA, it takes 12 to 15 years. More importantly, it costs close to $1 billion to bring a drug to market. It&apos;s also estimated that of the 1000s of molecules that are looked at, only a few will make it to clinical development, and following that, only five to six percent will survive and ended up being submitted for regulatory review.

So how do we choose the winning horse? On this episode of the I&apos;m Pharmacy Podcast we talk to Leslie Dan Faculty of Pharmacy researchers Professor Micheline Piquette Miller, Professor Raymond Reilly, and Dr. Jennifer Doucet on just what it takes to conduct translational research, and the excitement of seeing one&apos;s research leave the lab.</itunes:summary>
      <itunes:subtitle>The process of moving from a potential drug molecule to being on the shelf of a pharmacy is a long and winding journey. On average, from the time the molecule is discovered to when it&apos;s actually approved by the FDA, it takes 12 to 15 years. More importantly, it costs close to $1 billion to bring a drug to market. It&apos;s also estimated that of the 1000s of molecules that are looked at, only a few will make it to clinical development, and following that, only five to six percent will survive and ended up being submitted for regulatory review.

So how do we choose the winning horse? On this episode of the I&apos;m Pharmacy Podcast we talk to Leslie Dan Faculty of Pharmacy researchers Professor Micheline Piquette Miller, Professor Raymond Reilly, and Dr. Jennifer Doucet on just what it takes to conduct translational research, and the excitement of seeing one&apos;s research leave the lab.</itunes:subtitle>
      <itunes:keywords>patients, covid19, clinical trial, pharmaceutical sciences, radiopharmaceuticals, pharmacokinetics, drug, brain cancer, research, breast cancer, nuclear medicine, blood brain barrier, cancer, lab, assay</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>3</itunes:episode>
      <itunes:season>2</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">a1e0fc17-afe4-474d-92fd-54fb5d7d0472</guid>
      <title>S2.E2: On Target</title>
      <description><![CDATA[On this episode of the I'm Pharmacy Podcast, host Mina Tadrous finds answers to the questions: How do we figure out how where drugs work? Does this ever change? And are there more than just one way to find that final target?

Featuring discussions with Stèphane Angers, Director and Professor of U of T's Donnelly Centre, and Rob Bonin, Assistant Professor at the Leslie Dan Faculty of Pharmacy and Co-director of the U of T Centre for the Study of Pain. 
]]></description>
      <pubDate>Wed, 24 Nov 2021 11:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Stèphane Angers, Rob Bonin, Mina Tadrous)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="32573325" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/5045c45f-932e-4923-b518-1454ff233518/audio/5c073324-c217-4b7a-af30-cfcd0eb1ab7a/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S2.E2: On Target</itunes:title>
      <itunes:author>Stèphane Angers, Rob Bonin, Mina Tadrous</itunes:author>
      <itunes:duration>00:33:56</itunes:duration>
      <itunes:summary>On this episode of the I&apos;m Pharmacy Podcast, host Mina Tadrous finds answers to the questions: How do we figure out how where drugs work? Does this ever change? And are there more than just one way to find that final target?

Featuring discussions with Stèphane Angers, Director and Professor of U of T&apos;s Donnelly Centre, and Rob Bonin, Assistant Professor at the Leslie Dan Faculty of Pharmacy and Co-director of the U of T Centre for the Study of Pain.</itunes:summary>
      <itunes:subtitle>On this episode of the I&apos;m Pharmacy Podcast, host Mina Tadrous finds answers to the questions: How do we figure out how where drugs work? Does this ever change? And are there more than just one way to find that final target?

Featuring discussions with Stèphane Angers, Director and Professor of U of T&apos;s Donnelly Centre, and Rob Bonin, Assistant Professor at the Leslie Dan Faculty of Pharmacy and Co-director of the U of T Centre for the Study of Pain.</itunes:subtitle>
      <itunes:keywords>target, drug discovery, pain, genes, drug targets, memory, small molecule, cancer, gene therapy, disease</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>2</itunes:episode>
      <itunes:season>2</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">d357a3af-a5d7-4d3c-b8b5-47350ccee2f6</guid>
      <title>S2.E1 - Building the Foundation</title>
      <description><![CDATA[In 1921. At the corner of university and college in Toronto, two scientists Frederick Banting, and Charles best figured out how to remove insulin from a dog's pancreas. They extracted thick brown sludge.  Fast-forward 100 years, and the world is still benefiting from this momentous discovery.

As we kick-off the second season of the I'm Pharmacy Podcast, host Mina Tadrous starts with the pivotal question: Where do the ideas for new drugs start from? Where do they even start by inventing a new drug? And how does one find the next insulin? 
]]></description>
      <pubDate>Tue, 26 Oct 2021 10:00:00 +0000</pubDate>
      <author>pharmacy.comms@utoronto.ca (Mina Tadrous, Shana Kelley, Carolyn Cummins, Lorraine Bayliss)</author>
      <link>https://www.pharmacy.utoronto.ca/</link>
      <enclosure length="41682101" type="audio/mpeg" url="https://cdn.simplecast.com/audio/c64b8691-448c-43c5-9237-651f955192c4/episodes/bbbdb83f-412e-44ae-97b6-b34ec0e7d510/audio/3d5d11e3-971f-4df2-84c2-70dd3cb12856/default_tc.mp3?aid=rss_feed&amp;feed=cmy0BcAW"/>
      <itunes:title>S2.E1 - Building the Foundation</itunes:title>
      <itunes:author>Mina Tadrous, Shana Kelley, Carolyn Cummins, Lorraine Bayliss</itunes:author>
      <itunes:image href="https://image.simplecastcdn.com/images/7c2b3f0c-2241-4d7b-b7dd-f9a0c6bb30d6/dbb3bab6-b9e7-4616-a4a7-aea61a7d2ec8/3000x3000/podcast-icon-season-2-01.jpg?aid=rss_feed"/>
      <itunes:duration>00:43:23</itunes:duration>
      <itunes:summary>In 1921. At the corner of university and college in Toronto, two scientists Frederick Banting, and Charles best figured out how to remove insulin from a dog&apos;s pancreas. They extracted thick brown sludge.  Fast-forward 100 years, and the world is still benefiting from this momentous discovery.

As we kick-off the second season of the I&apos;m Pharmacy Podcast, host Mina Tadrous starts with the pivotal question: Where do the ideas for new drugs start from? Where do they even start by inventing a new drug? And how does one find the next insulin?</itunes:summary>
      <itunes:subtitle>In 1921. At the corner of university and college in Toronto, two scientists Frederick Banting, and Charles best figured out how to remove insulin from a dog&apos;s pancreas. They extracted thick brown sludge.  Fast-forward 100 years, and the world is still benefiting from this momentous discovery.

As we kick-off the second season of the I&apos;m Pharmacy Podcast, host Mina Tadrous starts with the pivotal question: Where do the ideas for new drugs start from? Where do they even start by inventing a new drug? And how does one find the next insulin?</itunes:subtitle>
      <itunes:keywords>pharmacist, pharmacy, pharmd, drugs, insulin, pharmaceutical sciences, medicine, chemistry, health sciences, disease targets, diabetes</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
      <itunes:season>2</itunes:season>
    </item>
  </channel>
</rss>